31.03.2022 • NewsSafic-AlcanPeople

Yann Lissillour Appointed CEO of Safic-Alcan

Martial Lecat and Philippe Combette will cease their functions within the Safic-Alcan Executive Committee on Apr. 1, 2022. At the same time, Combette, current Chairman of Safic-Alcan, will hand over the presidency of the group to Yann Lissillour. Lectat and Combette joined Safic-Alcan in June and October 1988 respectively.

Lecat will continue to chair the group's Supervisory Board and Philippe Combette will also remain a member of the Supervisory Board.

The company said that under the leadership of Lecat and Combette, Safic-Alcan has become a European leader in the distribution of specialty raw materials for the formulation industry. It has undergone a profound transformation, which began in the 1990s with a broad diversification of its distribution markets and an internationalization of its activities, both through organic and external growth.

Lissillour joined Safic-Alcan in 2000 and has held various commercial and managerial positions within the group. He has been in charge of acquisitions since 2016 and was appointed COO in November 2021.

Philippe Combette, Yann Lissillour and Martial Lecat, Safic-Alcan. Source:...
Philippe Combette, Yann Lissillour and Martial Lecat, Safic-Alcan. Source: Safic-Alcan

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read